Medicare cost differences between nursing home patients admitted with and without dementia

Bruce Stuart, Ann L. Gruber-Baldini, Cheryl Fahlman, Charlene C. Quinn, Lynda Burton, Illene H. Zuckerman, J. Rich Hebel, Sheryl Zimmerman, Puneet K. Singhal, Jay Magaziner

Research output: Contribution to journalArticle

Abstract

Purpose: Our objective in this study was to compare Medicare costs of treating older adults with and without dementia in nursing home settings. Design and Methods: An expert panel established the dementia status of a stratified random sample of newly admitted residents in 59 Maryland nursing homes between 1992 and 1995. Medicare expenditures per-person month (PPM) were compared for 640 residents diagnosed with dementia and 636 with no dementia for 1 year preadmission and 2 years postadmission. Multivariate analysis with generalized estimating equations was used to identify the source of Medicare cost differentials between the two groups. Results: Medicare expenditures peaked in the month immediately preceding admission and dropped to preadmission levels by the third month in a nursing home. Adjusted PPM costs postadmission for the dementia group as a whole were 79% (p <.001) of the Medicare costs of treating residents without dementia. For the subgroup of residents admitted without a Medicare qualified stay (MQS), those with dementia had Medicare costs of just 63% (p <.001) of those without dementia. Overall Medicare costs PPM were insignificantly different between the two groups admitted with a MQS. Implications: Whether nursing home residents are admitted with a MQS is the single most important factor in assessing treatment cost differentials between residents admitted with and without dementia. Failure to consider this factor may lead researchers and policy makers to misdirect their attention from the true source of the differential-dementia patients admitted without a qualifying stay.

Original languageEnglish (US)
Pages (from-to)505-515
Number of pages11
JournalGerontologist
Volume45
Issue number4
StatePublished - Aug 2005

Fingerprint

Medicare
Nursing Homes
Dementia
Costs and Cost Analysis
Health Expenditures
Administrative Personnel
Health Care Costs
Multivariate Analysis
Research Personnel

Keywords

  • Alzheimer's disease
  • Dementia
  • Health expenditures
  • Medicare
  • Medicare qualified stay
  • Nursing home

ASJC Scopus subject areas

  • Aging

Cite this

Stuart, B., Gruber-Baldini, A. L., Fahlman, C., Quinn, C. C., Burton, L., Zuckerman, I. H., ... Magaziner, J. (2005). Medicare cost differences between nursing home patients admitted with and without dementia. Gerontologist, 45(4), 505-515.

Medicare cost differences between nursing home patients admitted with and without dementia. / Stuart, Bruce; Gruber-Baldini, Ann L.; Fahlman, Cheryl; Quinn, Charlene C.; Burton, Lynda; Zuckerman, Illene H.; Hebel, J. Rich; Zimmerman, Sheryl; Singhal, Puneet K.; Magaziner, Jay.

In: Gerontologist, Vol. 45, No. 4, 08.2005, p. 505-515.

Research output: Contribution to journalArticle

Stuart, B, Gruber-Baldini, AL, Fahlman, C, Quinn, CC, Burton, L, Zuckerman, IH, Hebel, JR, Zimmerman, S, Singhal, PK & Magaziner, J 2005, 'Medicare cost differences between nursing home patients admitted with and without dementia', Gerontologist, vol. 45, no. 4, pp. 505-515.
Stuart B, Gruber-Baldini AL, Fahlman C, Quinn CC, Burton L, Zuckerman IH et al. Medicare cost differences between nursing home patients admitted with and without dementia. Gerontologist. 2005 Aug;45(4):505-515.
Stuart, Bruce ; Gruber-Baldini, Ann L. ; Fahlman, Cheryl ; Quinn, Charlene C. ; Burton, Lynda ; Zuckerman, Illene H. ; Hebel, J. Rich ; Zimmerman, Sheryl ; Singhal, Puneet K. ; Magaziner, Jay. / Medicare cost differences between nursing home patients admitted with and without dementia. In: Gerontologist. 2005 ; Vol. 45, No. 4. pp. 505-515.
@article{5735f21b54774d8ea7d3217b6c1b4ec2,
title = "Medicare cost differences between nursing home patients admitted with and without dementia",
abstract = "Purpose: Our objective in this study was to compare Medicare costs of treating older adults with and without dementia in nursing home settings. Design and Methods: An expert panel established the dementia status of a stratified random sample of newly admitted residents in 59 Maryland nursing homes between 1992 and 1995. Medicare expenditures per-person month (PPM) were compared for 640 residents diagnosed with dementia and 636 with no dementia for 1 year preadmission and 2 years postadmission. Multivariate analysis with generalized estimating equations was used to identify the source of Medicare cost differentials between the two groups. Results: Medicare expenditures peaked in the month immediately preceding admission and dropped to preadmission levels by the third month in a nursing home. Adjusted PPM costs postadmission for the dementia group as a whole were 79{\%} (p <.001) of the Medicare costs of treating residents without dementia. For the subgroup of residents admitted without a Medicare qualified stay (MQS), those with dementia had Medicare costs of just 63{\%} (p <.001) of those without dementia. Overall Medicare costs PPM were insignificantly different between the two groups admitted with a MQS. Implications: Whether nursing home residents are admitted with a MQS is the single most important factor in assessing treatment cost differentials between residents admitted with and without dementia. Failure to consider this factor may lead researchers and policy makers to misdirect their attention from the true source of the differential-dementia patients admitted without a qualifying stay.",
keywords = "Alzheimer's disease, Dementia, Health expenditures, Medicare, Medicare qualified stay, Nursing home",
author = "Bruce Stuart and Gruber-Baldini, {Ann L.} and Cheryl Fahlman and Quinn, {Charlene C.} and Lynda Burton and Zuckerman, {Illene H.} and Hebel, {J. Rich} and Sheryl Zimmerman and Singhal, {Puneet K.} and Jay Magaziner",
year = "2005",
month = "8",
language = "English (US)",
volume = "45",
pages = "505--515",
journal = "The Gerontologist",
issn = "0016-9013",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Medicare cost differences between nursing home patients admitted with and without dementia

AU - Stuart, Bruce

AU - Gruber-Baldini, Ann L.

AU - Fahlman, Cheryl

AU - Quinn, Charlene C.

AU - Burton, Lynda

AU - Zuckerman, Illene H.

AU - Hebel, J. Rich

AU - Zimmerman, Sheryl

AU - Singhal, Puneet K.

AU - Magaziner, Jay

PY - 2005/8

Y1 - 2005/8

N2 - Purpose: Our objective in this study was to compare Medicare costs of treating older adults with and without dementia in nursing home settings. Design and Methods: An expert panel established the dementia status of a stratified random sample of newly admitted residents in 59 Maryland nursing homes between 1992 and 1995. Medicare expenditures per-person month (PPM) were compared for 640 residents diagnosed with dementia and 636 with no dementia for 1 year preadmission and 2 years postadmission. Multivariate analysis with generalized estimating equations was used to identify the source of Medicare cost differentials between the two groups. Results: Medicare expenditures peaked in the month immediately preceding admission and dropped to preadmission levels by the third month in a nursing home. Adjusted PPM costs postadmission for the dementia group as a whole were 79% (p <.001) of the Medicare costs of treating residents without dementia. For the subgroup of residents admitted without a Medicare qualified stay (MQS), those with dementia had Medicare costs of just 63% (p <.001) of those without dementia. Overall Medicare costs PPM were insignificantly different between the two groups admitted with a MQS. Implications: Whether nursing home residents are admitted with a MQS is the single most important factor in assessing treatment cost differentials between residents admitted with and without dementia. Failure to consider this factor may lead researchers and policy makers to misdirect their attention from the true source of the differential-dementia patients admitted without a qualifying stay.

AB - Purpose: Our objective in this study was to compare Medicare costs of treating older adults with and without dementia in nursing home settings. Design and Methods: An expert panel established the dementia status of a stratified random sample of newly admitted residents in 59 Maryland nursing homes between 1992 and 1995. Medicare expenditures per-person month (PPM) were compared for 640 residents diagnosed with dementia and 636 with no dementia for 1 year preadmission and 2 years postadmission. Multivariate analysis with generalized estimating equations was used to identify the source of Medicare cost differentials between the two groups. Results: Medicare expenditures peaked in the month immediately preceding admission and dropped to preadmission levels by the third month in a nursing home. Adjusted PPM costs postadmission for the dementia group as a whole were 79% (p <.001) of the Medicare costs of treating residents without dementia. For the subgroup of residents admitted without a Medicare qualified stay (MQS), those with dementia had Medicare costs of just 63% (p <.001) of those without dementia. Overall Medicare costs PPM were insignificantly different between the two groups admitted with a MQS. Implications: Whether nursing home residents are admitted with a MQS is the single most important factor in assessing treatment cost differentials between residents admitted with and without dementia. Failure to consider this factor may lead researchers and policy makers to misdirect their attention from the true source of the differential-dementia patients admitted without a qualifying stay.

KW - Alzheimer's disease

KW - Dementia

KW - Health expenditures

KW - Medicare

KW - Medicare qualified stay

KW - Nursing home

UR - http://www.scopus.com/inward/record.url?scp=23044470303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044470303&partnerID=8YFLogxK

M3 - Article

C2 - 16051913

AN - SCOPUS:23044470303

VL - 45

SP - 505

EP - 515

JO - The Gerontologist

JF - The Gerontologist

SN - 0016-9013

IS - 4

ER -